
Conservation’s best outliers share three things.
Local knowledge. Shared decisions. Management that learns.
Every serving. No expiration date. Page 3 of 4.

Local knowledge. Shared decisions. Management that learns.

Functional testing on skin cells helped close difficult mitochondrial-disease diagnoses across samples from more than 30 medical centres.

The pollinators carried a precise biological treatment to as many as 88% of flowers.

The blight was first documented here. Now a restoration network is taking root.

Andfjorden now protects 1,848.5 square kilometres.

The fabric let light, rain and air through — while keeping insect mouths out.

Two fins. One layer of living muscle. A light to follow.

A pair of spinning eyes and a kite gave threatened seabirds a practical way around a deadly net.

Three remote counseling sessions and a phone tool helped young people make safer decisions in a rigorous trial.

A narrow strip through the Kilombero Valley is reconnecting savanna and rainforest — one elephant at a time.

The sky is filling with a migration Australia feared it had lost.

Four weeks of at-home magnetic-field sessions produced encouraging early signals for long-COVID cognitive impairment.

A small trial suggests the first medication for lymphedema may be getting closer.

A Phase 3 trial turned the walls of a surgical cavity into the radiation treatment.

A small scheduling change produced a surprisingly large clinical difference.

A painless test using urine and a vaginal swab showed it could accurately rule out womb cancer for most women with postmenopausal bleeding.

New York City planted its most trees in a decade and prioritized neighborhoods where extreme heat hits hardest.

A Cambridge-led study gave nicotinamide riboside to eight people with mitochondrial DNA disease. It was well tolerated and showed early signs of working.
THE MEADOW GREW BACK.
Ten traditional chain moorings were replaced with eco-moorings that move with the tide instead of scraping circles through the seabed. Five years later, the damaged patches had shrunk by an average 93.6%.

In a mouse model of multiple sclerosis, the experimental drug K-9 restored function after paralysis and vision loss had already set in. It has not been tested in people with MS.

In the TESEO trial, 450 adults received different benznidazole regimens. The 30-day, once-daily option matched the standard 60-day course in the trial and caused fewer side effects.
THE SCAN CAME BACK EMPTY.
Researchers at Texas Children's, Baylor College of Medicine and Seattle Children's reported in the New England Journal of Medicine that a child with hepatoblastoma had complete regression of disease after a novel immunotherapy given as part of the CARE study.
THE HAND FELT BACK.
Seventeen years after an amputation, Alexander “Avi” Davidson became the first participant to take Utah's thought-controlled bionic arm home — with a nerve interface that gives it a sense of touch.
NOBODY REINTRODUCED IT.
Mongabay reports a giant anteater turned up in an Argentine reserve on its own, decades after the species vanished locally — a case for letting recovering habitat do the work.